Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

FP7

THINPAD

Project ID: 601969
Finanziato nell'ambito di

Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance

Dal 2013-09-01 al 2016-08-31, progetto concluso | THINPAD Sito web

Dettagli del progetto

Costo totale:

EUR 7 451 080,80

Contributo UE:

EUR 5 691 950

Coordinato in:

Italy

Invito a presentare proposte:

FP7-HEALTH-2013-INNOVATION-2See other projects for this call

Meccanismo di finanziamento:

CP-FP - Small or medium-scale focused research project

Obiettivo

Informazioni correlate

Coordinatore

UNIVERSITA' DEGLI STUDI DI SIENA
Italy

Contributo UE: EUR 1 143 750


VIA BANCHI DI SOTTO 55
53100 SIENA
Italy
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Maurizio Botta
Tel.: +39 0577234306

Contact the organisation

Partecipanti

CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER
Spain

Contributo UE: EUR 722 750


CALLE ROSSELLO 149 PUERTA BJS
08036 BARCELONA
Spain
Activity type: Research Organisations
Contatto amministrativo: Pastora Martinez Samper
Tel.: +34932275707
Fax: +34932279205

Contact the organisation

UNIVERSITE DE STRASBOURG
France

Contributo UE: EUR 964 500


RUE BLAISE PASCAL 4
67081 STRASBOURG
France
Activity type: Higher or Secondary Education Establishments
Contatto amministrativo: Sandrine Schott
Tel.: +33368851124

Contact the organisation

IRBM SCIENCE PARK SPA
Italy

Contributo UE: EUR 2 386 700


VIA PONTINA KM 30600
00040 POMEZIA RM
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Micol Estrella
Tel.: +39 0691093269
Fax: +39 0691093654

Contact the organisation

VIROSTATICS SRL
Italy

Contributo UE: EUR 474 250


VIALE UMBERTO I 46
07100 SASSARI
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contatto amministrativo: Franco Lori
Tel.: +39 998639

Contact the organisation

Argomenti

Life Sciences